Bill Taranto joins Merck as Managing Director, Global Health Innovation Fund LLC and Executive Director, Global Health Innovation Group (GHI). Bill is responsible for building the GHI capability for Merck. He works across the Strategy Office, other Divisional and employee groups, and with external input to scout out new business opportunities outside traditional pharmaceutical and vaccine projects.
Bill works to build early concepts and drive business plan development for these opportunities and works on early incubation of new opportunities. Additionally, Bill is a member of the Innovative Ventures Board, a group that manages the identification and funding of a portfolio of emerging businesses. Bill serves on the leadership team with the Strategy Development Group, Strategy Realization Office, and Enterprise Wide Portfolio Management leaders to ensure the sharing of information and networking across the Strategy Office.
Prior to joining Merck, Bill spent 18 years at Johnson & Johnson in various marketing, sales and business development roles with increasing responsibility. In his previous position, Executive Director, Health Care Strategy & Alliances, Bill was responsible for evaluating the future healthcare environment, the viability and impact of health care channels, and the creation of new health care business models. Bill started his career as a sales representative for Janssen Pharmaceutica and progressed through various sales and marketing positions, including an assignment in Beerse, Belgium. Prior to joining J&J, Bill spent eight years in investment banking. Bill has a Bachelor of Business Administration from St. Bonaventure University.